MedTrace Logo

The Impact of an Art and Philosophy-based Intervention on Children's Eco-anxiety

NCT06937021 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2025-04-20

No results posted yet for this study

Summary

Objective: To examine the impact of climate change on children's mental health by comparing the effectiveness of an arts only intervention (ABI) and an arts and philosophy-based intervention (APBI) on children's eco-anxiety, tolerance to distress and hope for the future in school settings. The investigators hypothesized that the children assigned to the combined arts and philosophy intervention would show reductions in self-reported eco-anxiety, as well as increases in tolerance to distress and hope for the future in the context of climate change, when compared to children assigned to the arts-only intervention.

Setting: This study is conducted in public primary schools from England. Participants: Participants are students in grades 3 to 6. Main Outcomes and Measures: The primary outcome is self-reported eco-anxiety scores. Secondary outcomes are self-reported tolerance to distress, hope for the future and mental health (depression and anxiety symptoms).

Conditions

  • Eco-anxiety
  • Psychological Distress
  • Tolerance to Distress
  • Hope
  • Mental Health

Interventions

OTHER

Art and philosophy intervention (APBI)

8 session intervention delivered during school time. Each session involves an art activity with a corresponding philosophical discussion.

OTHER

Art based intervention (ABI)

A 8 session intervention delivered during school time. Each session involve a creative arts activity.

Sponsors & Collaborators

  • Social Sciences and Humanities Research Council of Canada

    collaborator OTHER

  • Bishop's University

    lead OTHER

Principal Investigators

  • Catherine Malboeuf-Hurtubise, PhD · Bishop's University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-03
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • United Kingdom

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06937021 on ClinicalTrials.gov